An Efficacy and Safety Study With Vandetanib to Treat Inoperable or Relapsed Malignant Mesothelioma - Related Studies

An Efficacy and Safety Study With Vandetanib to Treat Inoperable or Relapsed Malignant Mesothelioma

This study is currently recruiting participants.

Study NCT00597116. Last updated on April 30, 2008. Information provided by AstraZeneca

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Mesothelioma

2	More general conditions related to this trial
		Adenoma
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms, Glandular and Epithelial
		Neoplasms, Mesothelial

3	Interventions listed in this trial
		Vinorelbine
		Vandetanib

4	More general drug interventions related to this trial
		Antineoplastic Agents
		Antineoplastic Agents, Phytogenic
		Pharmacologic Actions
		Therapeutic Uses

5	Sponsors listed in this trial
		AstraZeneca